Annual Accounts Receivable
$143.00 K
+$143.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual accounts receivable is $143.00 thousand, with the most recent change of +$143.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, KROS annual accounts receivable has risen by +$143.00 thousand (+100.00%).
- KROS annual accounts receivable is now -99.21% below its all-time high of $18.00 million, reached on December 31, 2021.
Performance
KROS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$388.00 K
+$384.00 K+9600.00%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly accounts receivable is $388.00 thousand, with the most recent change of +$384.00 thousand (+9600.00%) on September 30, 2024.
- Over the past year, KROS quarterly accounts receivable has increased by +$245.00 thousand (+171.33%).
- KROS quarterly accounts receivable is now -97.84% below its all-time high of $18.00 million, reached on December 31, 2021.
Performance
KROS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
KROS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | +171.3% |
| 3 y3 years | +100.0% | - |
| 5 y5 years | - | - |
KROS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -99.2% | -100.0% | -97.8% | -100.0% |
| 5 y | 5-year | -99.2% | -100.0% | -97.8% | -100.0% |
| alltime | all time | -99.2% | -100.0% | -97.8% | -100.0% |
Keros Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $388.00 K(+9600.0%) |
| Jun 2024 | - | $4000.00(-98.2%) |
| Mar 2024 | - | $226.00 K(+58.0%) |
| Dec 2023 | $143.00 K(>+9900.0%) | $143.00 K(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $18.00 M(>+9900.0%) | $18.00 M(>+9900.0%) |
| Jun 2021 | - | $100.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Keros Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Keros Therapeutics?
- What is Keros Therapeutics annual accounts receivable year-on-year change?
- What is Keros Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Keros Therapeutics?
- What is Keros Therapeutics quarterly accounts receivable year-on-year change?
What is Keros Therapeutics annual accounts receivable?
The current annual accounts receivable of KROS is $143.00 K
What is the all time high annual accounts receivable for Keros Therapeutics?
Keros Therapeutics all-time high annual accounts receivable is $18.00 M
What is Keros Therapeutics annual accounts receivable year-on-year change?
Over the past year, KROS annual accounts receivable has changed by +$143.00 K (+100.00%)
What is Keros Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of KROS is $388.00 K
What is the all time high quarterly accounts receivable for Keros Therapeutics?
Keros Therapeutics all-time high quarterly accounts receivable is $18.00 M
What is Keros Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, KROS quarterly accounts receivable has changed by +$245.00 K (+171.33%)